MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1) (N-Term) Peptide
Quick Overview for MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1) (N-Term) Peptide (ABIN5513399)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- HLIQVEREKM QMELSHKRAR VELERAASTS ARNYEREVDR NQELLTRIRQ
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- MAD1L1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
-
Background
-
MAD1L1 is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosome are properly aligned at the metaphase plate. MAD1L1 functions as a homodimer and interacts with MAD2L1. MAD1L1 may play a role in cell cycle control and tumor suppression. Alternative splicing results in multiple transcript variants.
Alias Symbols: MAD1, PIG9, TP53I9, TXBP181
Protein Size: 718 -
Gene ID
- 8379
-
NCBI Accession
- NM_001013836, NP_001013858
-
UniProt
- Q9Y6D9
Target
-